Literature DB >> 2708209

Diastolic pressure determines autonomic responses to pressure perturbation in humans.

J S Sanders1, D W Ferguson.   

Abstract

Arterial baroreceptors reflexly regulate sympathetic and heart rate responses to alteration of blood pressure. The primary mechanical determinant of arterial baroreceptor activity in humans remains unclear. We examined the influence of systolic, diastolic, pulse, and mean arterial pressures on efferent muscle sympathetic nerve activity (MSNA, microneurography) and heart rate responses during perturbation of arterial pressure in 10 normal human subjects [age 25 +/- 2 (SE) yr]. We directly measured arterial pressure, heart rate, and MSNA during intravenous vasodilator infusion (nitroprusside, 6 +/- 1 micrograms.kg-1.min-1, n = 6; or hydralazine, 16 +/- 2 mg, n = 4) while central venous pressure was held constant by simultaneous volume expansion. Changes in arterial pressures were compared with changes in heart rate and MSNA over 3-min periods of vasodilator infusion during which we observed increases in systolic and pulse pressures with simultaneous decreases in mean and diastolic pressures. During vasodilator infusion, there were increases in systolic (124.2 +/- 2.1 to 131.7 +/- 2.9 Torr, P less than 0.001) and pulse pressures (57.0 +/- 2.2 to 72.7 +/- 2.7 Torr, P less than 0.001) although mean arterial pressure fell (88.0 +/- 2.6 to 80.4 +/- 2.7 Torr, P less than 0.001) because of decreases in diastolic pressure (67.2 +/- 3.0 to 59.0 +/- 2.7 Torr, P less than 0.001). The changes in arterial pressures were accompanied by simultaneous increases in heart rate (66.4 +/- 3.0 to 92.6 +/- 4.8 beats/min, P less than 0.001) and MSNA (327 +/- 59 to 936 +/- 171 U, P less than 0.005).(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Year:  1989        PMID: 2708209     DOI: 10.1152/jappl.1989.66.2.800

Source DB:  PubMed          Journal:  J Appl Physiol (1985)        ISSN: 0161-7567


  9 in total

1.  Blood pressure levels and variance assessed by ambulatory monitoring: optimal parameters.

Authors:  F E Yates; L A Benton
Journal:  Ann Biomed Eng       Date:  1990       Impact factor: 3.934

2.  After-effects of exercise on haemodynamics and muscle sympathetic nerve activity in young patients with dilated cardiomyopathy.

Authors:  K Hara; J S Floras
Journal:  Heart       Date:  1996-06       Impact factor: 5.994

3.  Cardiovascular regulation in the period preceding vasovagal syncope in conscious humans.

Authors:  P O O Julu; V L Cooper; S Hansen; R Hainsworth
Journal:  J Physiol       Date:  2003-04-04       Impact factor: 5.182

4.  Changes in central venous pressure with vasoactive drug injections in humans.

Authors:  Elizabeth A Martin; Nisha Charkoudian
Journal:  Clin Auton Res       Date:  2005-04       Impact factor: 4.435

5.  Reduced portosystemic hemodynamic responsiveness after orthostasis in patients with cirrhosis.

Authors:  T Iwao; A Toyonaga; M Ikegami; M Sumino; K Oho; M Sakaki; H Shigemori; K Tanikawa; J Iwao
Journal:  Dig Dis Sci       Date:  1993-07       Impact factor: 3.199

6.  Respiratory sinus arrhythmia: opposite effects on systolic and mean arterial pressure in supine humans.

Authors:  M Elstad; K Toska; K H Chon; E A Raeder; R J Cohen
Journal:  J Physiol       Date:  2001-10-01       Impact factor: 5.182

7.  Diastolic aortic pressure rise during percutaneous transluminal coronary angioplasty: an index of left ventricular systolic dysfunction.

Authors:  I A Paraskevaidis; Z S Kyriakides; A K Kassimatis; T P Apostolou; G K Kalopisis; D T Kremastinos
Journal:  Br Heart J       Date:  1995-09

8.  Vasopressor use in the critical care unit for treatment of persistent post-carotid artery stent induced hypotension.

Authors:  Mohan Reddi Nandalur; Howard Cooper; Lowell F Satler; Kiran R Nandalur; John R Laird
Journal:  Neurocrit Care       Date:  2007       Impact factor: 3.210

9.  Respiration-synchronous fluctuations in stroke volume, heart rate and arterial pressure in humans.

Authors:  K Toska; M Eriksen
Journal:  J Physiol       Date:  1993-12       Impact factor: 5.182

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.